Home
>
National Drug Code (NDC)
>
Bumetanide
Bumetanide - 10019-506-45 - (Bumetanide)
Drug Information of Bumetanide
| Product NDC: | 10019-506 |
| Proprietary Name: | Bumetanide |
| Non Proprietary Name: | Bumetanide |
| Active Ingredient(s): | .25 mg/mL & nbsp; Bumetanide |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bumetanide
| Product NDC: | 10019-506 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA079196 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090127 |
Package Information of Bumetanide
| Package NDC: | 10019-506-45 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-506-45) > 4 mL in 1 VIAL, SINGLE-DOSE (10019-506-37) |
NDC Information of Bumetanide
| NDC Code | 10019-506-45 |
| Proprietary Name | Bumetanide |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-506-45) > 4 mL in 1 VIAL, SINGLE-DOSE (10019-506-37) |
| Product NDC | 10019-506 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bumetanide |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20090127 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | BUMETANIDE |
| Strength Number | .25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |
